智通财经APP讯,先声药业(02096)发布公告,于2025年12月1日,会议通过根据2021年受限制股份单位计划按零代价向合共97名合资格参与者授出合共1540.81万份受限制股份单位(相当于1540.81万股相关股份),惟须待承授人接纳。
奖励的授出将透过动用受托人持有1540.81万股股份作出,有关股份与根据2021年受限制股份单位计划的规则过往授出惟已失效的受限制股份单位有关。
智通财经APP讯,先声药业(02096)发布公告,于2025年12月1日,会议通过根据2021年受限制股份单位计划按零代价向合共97名合资格参与者授出合共1540.81万份受限制股份单位(相当于1540.81万股相关股份),惟须待承授人接纳。
奖励的授出将透过动用受托人持有1540.81万股股份作出,有关股份与根据2021年受限制股份单位计划的规则过往授出惟已失效的受限制股份单位有关。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.